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Purpose: To screen for sequence variations in the IDO gene that encodes indoleamine 2, 3- dioxygenase (IDO), the first
rate limiting enzyme involved in the tryptophan catabolism which results in the production of UV filters playing a role in
the maintenance of lens transparency.
Methods: We conducted a case-control study to screen for sequence changes in the IDO gene and associated demographic
risk factors in patients with nuclear (NC-110), cortical (CC-110) and Posterior sub capsular (PSC-111) cataracts in
comparison to normal controls (210) from Hyderabad, India.
Results: Among the cataract types studied high risk was observed for CC and PSC types in female patients, individuals
with low body mass index and smoking habit. Cataract development had early onset more frequently in cases of PSC
followed by CC and NC. Screening by single strand conformation polymorphism (SSCP) revealed mobility shifts in 6 of
the 331 patient (3 with NC and 3 with PSC) samples which upon sequencing confirmed the presence of G→A transition
(c.422+90G→A; rs4613984) in the intron downstream to exon 4 of IDO which was further tested by RFLP anlaysis using
the HhaI restriction enzyme. Of the 6 patients, one with nuclear cataract showed homozygosity and the remaining five
showed heterozygosity for the substitution. None of the control samples showed this variation.
Conclusions: It is possible that the substitution c.422+90G→A; rs4613984 in an intron downstream to exon 4 of IDO
may be related with cataract formation among the aged.
Cataract  is  an  age  related  condition  characterized  by
progressive opacification of the ocular lens leading to visual
impairment and blindness. It accounts for an estimated 16
million cases world wide, with approximately half of all the
cases originating from Africa and Asia [1]. Ultraviolet (UV)
light, diabetes, aging and female gender are identified as the
major  risk  factors  for  the  development  of  cataracts  [2,3].
Formation  of  cataract  is  an  outcome  of  numerous  post
translational modifications of crystalline proteins in the lens
involving  oxidation,  cross-linking,  truncation,  and
aggregation [4]. The modified proteins accumulate in the lens
with age adding color, fluorescence, and insolubility [5,6].
Protein  modification  may  also  result  due  to  thermal  or
photochemical reaction of UV filters like kunurenine (KN)
and 3hydroxy kynurenine (3-OHKN) [7-9] formed during
tryptophan catabolism. The UV filters get covalently attached
to  the  lens  proteins,  influence  protein  functionality  and
increase their susceptibility to UV light [10,11]. In normal
lens, with aging, the levels of free UV filters are decreased
and the proteins in the lens get modified by UV [8,12-15]. In
cataract lens the levels of free and protein bound UV filters
are found to be much lower as compared to normal lenses of
the same age while the levels of tryptophan – the precursor of
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kynurenine pathway is much higher [12,14,16]. This indicates
possible  impairment  in  the  catabolism  of  tryptophan  in
cataractous lenses and also degradation of UV filters under
oxidizing conditions [17]. From their work on the OXYS
(cataract model) and Wistar (control) rats Snytnikova et al.
[17] found a dramatic change between the two strains in the
content of tryptophan and kynurenine during the postnatal
development. They concluded that the kynurenine pathway of
tryptophan  catabolism  does  not  play  a  significant  role  in
cataract  development  in  rat  lens  at  the  stages  of  cataract
manifestation but an imbalance in the kynurenine pathway at
early stages can create a metabolic background for future
cataract development. Studies on human lenses in early stages
of  cataract  are  limited  and  the  reports  available  on  the
biochemical contents are on the developed cataracts that are
surgically removed. Street et al. [16] found the levels of UV
filter  compounds,  UV  filter  precursor  amino  acid  i.e.,
tryptophan, tyrosine, and uric acid to differ in Indian cataract
lenses when compared to control lenses. They suggested that
the metabolism of large proportion of patients with cataract
may  be  different  from  persons  with  normal  lenses  with
possible  upregulation  of  aminoacid  transporter  system  in
cataract  patients.  As  the  levels  of  kynurenine  were  not
significantly  different  in  cataract  lenses  as  compared  to
normal lenses they also concluded that there could be a defect
in the lenticular UV filter pathway at one or both the steps that
convert kynurenine to 3OHKG.
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1203The first step in the process of tryptophan catabolism
leading to the production of UV filters involves the oxidative
cleavage of the pyrrole ring of tryptophan to N-formyl-L-
kynurenine which is catalyzed by the enzyme indoleamine 2,3
dioxygenase (IDO) [18,19]. The enzyme is widely expressed
in placental trophoblast giant cells of fetal origin, epididymis,
gut, lymph nodes, spleen, thymus and lungs. Overexpression
of the enzyme is seen in many human diseases like different
types  of  cancers,  chronic  infectious  diseases,  allergy  and
autoimmune disease etc [20-22]. Apart from its key function
of downregulating, the T-cell immunity, the enzyme also acts
as scavenger of free radicals generated in tissues like lens
which  may  help  to  prevent  lens  opacification  [23].
Interindividual  differences  in  IDO  expression  are  also
reported implicating inherited variations in the gene sequence.
The IDO protein is encoded by the gene designated as IDO or
INDO (OMIM 147435) and is located on chromosome 8p12–
11 [24]. IDO is a single copy gene comprising 10 exons
spanning 15 kb and codes for a protein of 403 amino acids.
Sequence  variations  are  reported  in  the  IDO  gene  in  the
NCBI database describing 43 variants in human IDO gene
covering exon and intronic region and their boundaries but
with no clinical associations including cataract. Arefayene et
al. [25] in their study using Coriell DNA samples (48 African
Americans  and  48  Caucasian  Americans)  found  24  IDO
variants of which 17 were in exons, introns or exon/intron
boundaries  while  7  were  within  1.3  kb  upstream  of  the
translation start site. They identified 22 putative transcription
binding sites within 1.3 kb upstream of the translation site and
two of the SNPs detected were located in GATA3 and FOXC1
sites. Amani et al. [26] identified 10 SNPs; four exonic and
six  intronic  regions  of  IDO  gene  in  Iranian  women  with
recurrent spontaneous abortions of which three have been
registered with the NCBI single nucleotide polymorphism
(SNP)  database  which  were  however  not  associated  with
recurrent spontaneous abortions.
The  sequence  variations  in  IDO  gene  may  have  a
functional role influencing UV filter production and cataract
formation. Hence, the present study was performed to screen
for variations in the IDO gene in Indian patients with different
types of age related cataracts (ARC).
METHODS
We attempted to screen all the ten exons and exon-intron
boundaries of IDO gene for sequence variations and their
possible pathogenic role leading to age related cataracts by
single strand confirmation polymorphism (SSCP) followed by
sequencing  of  samples  with  mobility  shift.  The  patients
studied were from among the inpatients recruited for surgery
at Sarojini Devi Eye Hospital and Institute of Ophthalmology,
Hyderabad, India. The type of cataract was determined by the
ophthalmologists concerned following LOC- III classification
[27]. A total of 331 cases ([110-Nuclear cataract [NC]; 110-
Cortical  cataract  [CC],  and  111-Posterior  sub  capsular
cataract [PSC]) were screened along with 210 healthy normal
individuals selected at random by personal contacts, by house
visits and from among the employees of Government and
private organizations with the provision for annual health
check up. The patients and controls were explained about the
purpose and outcome of the study and only those who gave
their consent to participate in the investigations by providing
the blood samples and demographic history were considered.
The  study  was  approved  by  our  Institutional  Ethical
Committee.
Inclusion  and  exclusion  criteria:  Only  patients  with
primary cataracts were included in the present study and those
arising due to trauma, action of toxins, inflammations and
degenerative  ocular  diseases  were  excluded.  In  addition,
patients  with  associated   conditions   like  diabetes,  hyper-
tension, myopia, glaucoma, thyroid syndromes, and  cataract 
inducing  medications  (like  steroids)  were  not  considered.
Control  subjects  were  also  without  the  history  of  cataract,
diabetes, hypertension, thyroid and other ocular diseases.
From all the patients and controls, information pertaining
to sex, age, age at onset, duration of disease, type of cataract,
information on habits, diet, and detailed medical history along
with  three  generation  pedigrees  were  collected  using  a
proforma prepared specifically for this study.
Procedures: Venous blood samples (5 ml) were collected
from all the patients and controls in EDTA vaccutainers for
isolation  of  DNA  by  rapid  non  enzymatic  method  which
involves salting out of the cellular proteins by dehydration and
precipitation  with  saturated  sodium  chloride  solution
followed by extraction with absolute alcohol [28]. Ten sets of
primers  were  designed  to  screen  the  DNA  samples
for variations    in    exon    and    exon-intron    boundaries    of
IDO gene (Table1). The present paper refers to the variation
detected in the 5′ intronic boundary downstream to exon 4 by
SSCP followed by sequencing and restriction fragment length
polymorphism (RFLP) analysis. The region was amplified
using 10 µl PCR mix containing 1× PCR buffer, 200 µM
dNTPs (Sigma Aldrich, Schnelldorf, Germany), 0.25 units of
Taq polymerase (Sigma Aldrich) and 2.5 pmols of forward
(5′-CAG GAG CAA GAC TCC ATC TC 3′) and reverse (5′-
GTA GTG GTA GAC ACA GCA GTC 3′) primers (Ocimum
Biosolutions  (India)  Ltd,  Hyderabad,  India).  The  PCR
conditions applied were of initial denaturation at 95 °C for 5
min, followed by 30 cycles at 95 °C for 1 min, 62 °C for 40 s,
72 °C for 1 min, and a final extension at 72 °C for 5 min. The
PCR products were denatured in LIS buffer (10% sucrose,
0.01% bromophenol blue and 0.01% xylene cyanol) at 95 °C
for 10 min and electrophoresed for SSCP analysis using 10%
polyacrylamide gel (37.5:1) for 18 h at 100 V. Later the gels
were washed with distilled water, treated with ethanol acetic
acid fixative (20:1) for 10 min and stained in dark with 0.1%
silver nitrate (Himedia) for 10 min. Later the stain solution
was  replaced  by  developing  solution  (sodium  hydroxide
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and left for about 10 min under constant shaking for the bands
to develop. The banding pattern was then recorded in the Gel
documentation system (Spectronics, Westbury, NY).
The PCR products showing mobility shift on SSCP were
sequenced on an ABI 3100 DNA sequence analyzer (Vimta
labs Ltd, Hyderabad, India) which revealed the presence of
c422+90G→A substitution. This substitution created a loss of
restriction site for HhaI enzyme. All the patient and control
samples were digested with 2 units of the enzyme at 37 °C
followed by electrophoresis in 2% agarose gel with ethidium
bromide. The RFLP detected single fragment of 378 bp for
AA homozygotes arising due to loss of site, two fragments of
295 and 83 bp for GG homozygotes with a single restriction
site and three fragments for heterozygotes GA of 378, 295,
and 83 bp in length.
RESULTS
The results on demographic parameters showed high risk for
cataracts  in  females  with  a  preponderance  of  55.3%  as
compared to males (44.7% Table 2), the frequency being
highest in cases of PSC (60.4%) followed by CC (54.5%) and
NC (50.9%). The ages of patients ranged from 40 to 85 years
of age and that of controls from 40 to 80 years of age. The
mean  ages  recorded  for  patients  was  58.7±0.23
(NC-61.3±0.23, CC-58.1±0.23, and PSC-56.6±0.22) and for
controls 49.1±0.10. Considering age at onset of cataract the
mean values were 57.7±0.22 for the patients in general and
comparatively  with  delayed  onset  in  patients  of  NC
(60.4±0.23)  followed  by  CC  (57.5±0.23)  and  PSC
(55.6±0.22). The frequency of cases with early age at onset
(<50) was high in PSC (31.5%) followed by CC (26.4%) and
NC (11.8%). The frequency of over weight patients was less
in cases (7.3%) as compared to controls (30.8%). Smokers
among patients were higher in frequency (55.4%) and that of
alcoholics lesser (39.2%) as compared to controls (smokers
39.4%,  alcoholics  47.0%).  The  present  findings  are  in
compliance with the earlier reports from Framingham, Beaver
Dam and Barbodas Eye studies and also other studies from
various  geographical  regions  suggesting  association  of
different types of cataracts with female sex [29-33], cigarette
smoking [34-43] and low body mass index [44-46].
Screening for sequence variations revealed 6 out of 331
patient samples with mobility shift on SSCP analysis which
on  sequencing  detected  c.422+90G→A  (rs4613984)
substitution in the intronic region down stream to exon 4. Of
the 6 patients three were with NC (one female and two males),
three with PSC (two females and a male), and none with CC.
All these patients were above 55 years except for one case of
PSC who was a female of 25 years. This patient reported onset
of cataract 6 months prior to this study and was not having
any  vision  defects  before  that.  Hence  this  patient  was
considered to have early onset of age related cataract rather
than of juvenile onset cataract. Only one case of NC showed
homozygosity (AA) for the variation while the remaining five
samples  were  heterozygotes  (GA).  None  of  the  control
samples  studied  showed  the  presence  of  c.422+90G→A
(rs4613984) substitution neither on SSCP or RFLP analysis.
We may mention here that the c.422+90G→A (rs4613984)
substitution  registered  in  the  NCBI  database  describes  5
studies with the incidence of GG homozygotes alone among
four  populations  viz.,  Europeans,  two  different  groups  of
Asian population, and Sub-Saharan African population. In the
5th report (pilot_1_CEU_low_coverage_panel) allele A was
found with a low frequency of 0.05. No correlation of IDO
polymorphisms have been made with any clinical conditions
in these studies. In the present study the observation of AA
homozygotes and GA heterozygotes made only in patients and
not in controls prompts us to consider this sequence change
as a probable mutation with pathogenesis for NC and PSC
types of cataracts. We have not found any studies on the
IDO gene polymorphisms with reference to cataracts so far.
DISCUSSION
Indoleamine  2,  3  dioxygenase  (IDO)  is  the  rate  limiting
enzyme in tryptophan catabolism which oxidizes tryptophan
into  kynurinine,  initially  found  to  affect  the  defense
mechanism against pathogens. The enzyme activity is shown
to be associated with several diseases including autoimmune
disorders, cancers, depression, altered maternal tolerance of
paternal antigens and apoptosis. The enzyme catalyzes the
TABLE 1. LIST OF PRIMERS USED TO SCREEN CODING REGIONS AND EXON-INTRON BOUNDARIES OF THE IDO GENE.
Primer sets Forward (5′-3′) Reverse (5′-3′)
Exon 1 CAAAAGTGGAAGTAATTTCTCAC GAAGTTAACTTGGCCAGGTAAG
Exon 2&3 GAAGGCAAGGCATACTATCAG GGAAAGTTAAATGTAAATTAGATG
Exon 4 CAGGAGCAAGACTCCATCTC GTAGTGGTAGACACAGCAGTC
Exon 5 GCTTTTTCTTTTTACCTATGTCTTACC TGGAGTCTATTGATAAACCTACATTCA
Exon 6 GATAGTAAGGCCTGCCACAC GTTTAGGCTCCGAAGTGATTG
Exon 7 CTGGACAACTGAGCGAGACTC CTATTCTACACCTGGAACATTTG
Exon 8 CATTATCAGTTGTACACAACACC GGATATTAGGGACCAACCAAG
Exon 9 GGATCATGAAATCCATCTCTTG GTGCTTTGTAGATATCCAAATAC
Exon 10A CAGTGAATGCTATATTGGTGATC GCAGATGGTAGCTCCTCAGG
Exon 10B CCTGAGGAGCTACCATCTGC GTAATGACAGGAATGCATACAG
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kynurenine that affect the transparency of ocular lens because
of their degradation and modification of lenticular proteins by
them with aging. Large inter-individual variations observed
in  the  activity  of  IDO  in  clinical  conditions  have  been
attributed to inherited genetic variability. Though few studies
describing the frequencies of the variants in some normal
populations are registered in the NCBI SNP database, and by
Arefayene  [25]  on  the  African  American  and  American
Caucasians  samples,  only  one  report  is  published  on  the
association of Indoleamine 2,3 dioxygenase polymorphisms
with recurrent spontaneous abortions in Iranian women with
negative results [26].
The present study is the first report with the c.422+90
G→A  substitution  in  the  intron  downstream  to  exon  4
occurring in 6 cases of cataracts of which only one patient was
a homozygote and remaining 5 were heterozygotes for the
change  detected.  Since  none  of  the  control  samples  were
detected to harbor this change, we propose the variability to
be associated with cataract formation. It may be mentioned
here that this variation reported in normal populations all
showed the presence of GG genotypes and none were of AA
or AG genotypes. Thus the variation c.422+90 G→A found
in the present study appears to be pathogenically related to
cataract development.
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